metaraminol has been researched along with Granulocytic Leukemia, Chronic in 1 studies
Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| FREIREICH, EJ | 1 |
| LEVIN, RH | 1 |
| WHANG, J | 1 |
| CARBONE, PP | 1 |
| BRONSON, W | 1 |
| MORSE, EE | 1 |
1 other study available for metaraminol and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
THE FUNCTION AND FATE OF TRANSFUSED LEUKOCYTES FROM DONORS WITH CHRONIC MYELOCYTIC LEUKEMIA IN LEUKOPENIC RECIPIENTS.
Topics: Anti-Bacterial Agents; Blood Transfusion; Cell Division; Humans; Leukemia; Leukemia, Myelogenous, Ch | 1964 |